Levosimendan improves hemodynamics and coronary flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction and left ventricular dysfunction

This publication has 26 references indexed in Scilit:

• The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia
  Journal of the American College of Cardiology, 2004
• Functional Role of Potassium Channels in the Vasodilating Mechanism of Levosimendan in Porcine Isolated Coronary Artery
  Cardiovascular Drugs and Therapy, 2003
• Further Evidence for the Cardiac Troponin C Mediated Calcium Sensitization by Levosimendan: Structure-response and Binding Analysis with Analogs of Levosimendan
  Journal of Molecular and Cellular Cardiology, 2000
• Comparison of the Vasorelaxing Effect of Cromakalim and the New Inodilator, Levosimendan, in Human Isolated Portal Vein
  Journal of Pharmacy and Pharmacology, 2000
• Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting
  Published by Oxford University Press (OUP) ,1998
• Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes
  European Journal of Pharmacology, 1997
• Comparative efficacy of short‐term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction
  Clinical Cardiology, 1996
• Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan
  Journal of Molecular and Cellular Cardiology, 1995
• Intravenous enoximone or dobutamine for severe heart failure after acute myocardial infarction: a randomized double-blind trial
  European Heart Journal, 1993
• Effects of dobutamine in patients with acute myocardial infarction
  The American Journal of Cardiology, 1977